Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia

Area of Science:

• Oncology
• Pharmacology
• Cell Biology

Background:

• Non-psychoactive cannabinoid, cannabidiol (CBD), exhibits anticancer properties across various tumor types.
• Proposed mechanisms for CBD's action involve cannabinoid receptors and ion channels, but its precise targets remain under investigation.

Purpose of the Study:

• To investigate the sensitivity of T-cell acute lymphoblastic leukemia (T-ALL) cell lines to CBD treatment.
• To elucidate the molecular mechanisms underlying CBD's effects on T-ALL cells.

Main Methods:

• Treatment of T-ALL cell lines and healthy T cells with CBD.
• Assessment of CBD's effects on cell viability and mitochondrial function.
• Investigation of cannabinoid receptor and ion channel involvement.

Main Results:

• T-ALL cell lines were highly sensitive to CBD, unlike healthy T cells.
• CBD's efficacy was independent of cannabinoid receptors or plasma membrane calcium channels.
• CBD directly targeted mitochondria, causing calcium overload, mitochondrial transition pore formation, and cell death.

Conclusions:

• CBD demonstrates significant anticancer activity specifically against T-ALL cells.
• Mitochondrial dysfunction, particularly calcium handling, is a key mechanism for CBD-induced T-ALL cell death.
• CBD presents a promising candidate for integration into T-ALL chemotherapeutic regimens.